期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
玻璃体腔注射康柏西普联合全视网膜激光光凝治疗不同分期增殖性糖尿病视网膜病变 被引量:10
1
作者 单田慧 俞嘉宣 +4 位作者 刘春莉 高翔 原公强 孙晓蕾 张静静 《国际眼科杂志》 CAS 北大核心 2023年第8期1242-1249,共8页
目的:评价玻璃体腔注射康柏西普联合全视网膜激光光凝(PRP)治疗不同分期增殖性糖尿病视网膜病变(PDR)的疗效。方法:回顾性病例研究。选取于2018-01/2020-06期间初次就诊于我院的PDR患者100例100眼,入选患者均行玻璃体腔注射康柏西普治疗... 目的:评价玻璃体腔注射康柏西普联合全视网膜激光光凝(PRP)治疗不同分期增殖性糖尿病视网膜病变(PDR)的疗效。方法:回顾性病例研究。选取于2018-01/2020-06期间初次就诊于我院的PDR患者100例100眼,入选患者均行玻璃体腔注射康柏西普治疗,并在注药后1mo内进行PRP治疗。依据我国糖尿病视网膜病变临床诊疗指南,根据眼底荧光血管造影及眼底检查结果分为3组:A组早期PDR组34眼;B组高危PDR组43眼,C组纤维增生早期PDR组23眼。观察3组患者基线情况以及联合治疗后1、3、6mo和末次随访时的最佳矫正视力(BCVA)、黄斑中心厚度(CMT)、玻切手术率,视网膜脱离率。结果:本研究平均随访14.60±11.64mo(6-52mo)。患者平均年龄为54.22±9.32岁。治疗后行玻切手术患者15眼(15.0%),3组玻璃体切除率分别为2.9%(A组)、13.9%(B组)、34.7%(C组)。治疗后无视网膜脱离情况发生。末次随访较基线水平,3组患者治疗后BCVA和CMT值均有改善。结论:玻璃体腔注射康柏西普联合PRP治疗不同分期PDR是安全有效的,可有效提高患者视力,减轻视网膜水肿。 展开更多
关键词 增殖性糖尿病视网膜病变 玻璃体切除术 全视网膜光凝 康柏西普
下载PDF
Surgical management of fungal endophthalmitis resulting from fungal keratitis 被引量:5
2
作者 Yan Gao Nan Chen +3 位作者 Xiao-Guang Dong gong-qiang yuan Bin Yu Li-Xin Xie 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2016年第6期848-853,共6页
AIM: To report the fungal organisms, clinical features, surgical treatment strategies, and outcomes of patients with culture-proven exogenous fungal endophthalmitis (EFE) secondary to keratitis, and evaluate the ro... AIM: To report the fungal organisms, clinical features, surgical treatment strategies, and outcomes of patients with culture-proven exogenous fungal endophthalmitis (EFE) secondary to keratitis, and evaluate the role of surgery in the treatment. METHODS: The clinical records of 27 patients (27 eyes) with culture-proven EFE resulting from fungal keratitis treated at Shandong Eye Institute from January 2007 to January 2015 were retrospectively reviewed. Information about fungal culture results, clinical features, surgical procedures, and final visual acuity was obtained. RESULTS: There were 39 positive culture results from samples of cornea, hypopyon, vitreous and lens capsule, accounting for 56%, 26%, 15% and 2.5%, respectively. Fusarium was identified in 44% (12/27) of the eyes, followed by Aspergillus in 22% (6/27). Posterior segment infection was involved in 78% (21127) of the patients. The corneal infection was larger than 3 mmx3 mm in 89% (24/ 27) of the patients, and 22% (6/27) of them had the entire cornea, and even the sclera involved. Three eyes had silicone oil tamponade, and two eyes had retinal detachment. Twenty-two eyes (81.5%) underwent penetrating keratoplasty (PKP), and over half of them (545%) were operated within 3d from the onset of antifungal therapy. Fourteen eyes (52%) underwent intracameral antifungal drug injection, and three of them required repeated injections. Fifteen eyes (55.6%) underwent pars plana vitrectomy (PPV). The rate of the eyes undergoing PPV as the initial surgical procedure was 60% (9/15), lower than 77% in PKP. Intravitreal injection was given in 59% of the eyes (16/27), and 75% of them required repeated injections. The final visual acuity was 20/100 or better in 37% of the eyes, and better than counting fingers in 55.6% of the eyes. Five eyes (18.5%) were eviscerated. In the two eyes with concurrent retinal detachment, one achieved retinal reattachment, and the other was eviscerated. In the three eyes with silicone oil tamponade, two eyes received silicone oil removal, and the other one was eviscerated. CONCLUSION: Fusarium and Aspergillus are the dominant pathogens in EFE resulting from keratitis. Aggressive antifungal surgeries including multiple intravitreal injections, PKP and core vitrectomy (especially in the initial surgery) are helpful procedures to improve prognosis of severe EFE secondary to keratitis. 展开更多
关键词 exogenous fungal endophthalmitis fungalkeratitis penetrating keratoplasty VITRECTOMY antifungaltherapy retinal detachment surgery
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部